《J Cardiovasc Pharmacol Ther》服用β-受体阻滞剂与心肺适能的关系 几十年来,β-肾上腺素受体拮抗剂或β-受体阻滞剂(BBS)被用于治疗多种心血管疾病。β-受体阻滞剂对心血管疾病的主要药理作用是阻断心脏和血管β受体。β阻断β1受...
Circ Cardiovasc Interv. 2014;7(2):225-232. Crimi G, Ferlini M, Gallo F, et al. Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: a post-hoc analysis of a randomized trial. Int J Cardiol. 2014;177(2):500-502. Savaj S, Savoj J, Jeb...
J Cardiovasc Pharmacol Ther 2013;18:533-43.Panchal HB; Shah T; Pate1 P;.Comparison of on-treatment platelet reactivity between triple antiplatelet therapy... pmhdev - 《Centre for Reviews & Dissemination》 被引量: 20发表: 2013年 Mast cell inhibition attenuates myocardial damage, adverse remodeli...
J. Cardiovasc. Pharmacol.Author(s): S Lahlou, C Magalhães, M Siqueira, E. A. T. de FIGUEIREDO, L. F. L. INTERAMINENSE, W. MAIA, E. C. P. M. Sousa Publication date: 1994 Read this article at ScienceOpen Bookmark There is no author summary for this article yet. Authors ...
2023 - Repeated levosimendan infusions in the management of advanced heart failure: review of the evidence and meta-analysis of the effect on mortality. November 22, 2023 [MEDLINE Abstract] ALKBH5 regulates N(6)-methyladenosine (m6A) methylation of MG53 to attenuate myocardial infarction by inhibiti...
Q3JCR分区 1.5影响因子 ISSN:1734-9338 E-ISSN:1897-4295 国际简称:POSTEP KARDIOL INTER 出版国家或地区:POLAND 研究方向:医学 - 心血管系统 是否预警:否 创刊时间:2005 H-index:12 出版周期:Quarterly 出版语言:Polish/English 年发文量:41 文章自引率:0.15... ...
Age-Related Considerations in Cardio-Oncology. January 01, 2021 [MEDLINE Abstract] Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data. January 01, 2021 ...
Inhibition of Na+/H+ Exchanger With EMD 87580 does not Confer Greater Cardioprotection Beyond Preconditioning on Ischemia-Reperfusion Injury in Normal Dogs. January 01, 2018 [MEDLINE Abstract] Energy Expenditure May Explain Why Coffee Drinkers Have Lower Mortality. ...